vs
Side-by-side financial comparison of Crinetics Pharmaceuticals, Inc. (CRNX) and Rent the Runway, Inc. (RENT). Click either name above to swap in a different company.
Rent the Runway, Inc. is the larger business by last-quarter revenue ($10.6M vs $6.2M, roughly 1.7× Crinetics Pharmaceuticals, Inc.). Rent the Runway, Inc. runs the higher net margin — 721.7% vs -1993.4%, a 2715.1% gap on every dollar of revenue.
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
Rent the Runway is an American e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories. It was founded in November 2009 by Jennifer Hyman and Jennifer Fleiss and is based in New York City.
CRNX vs RENT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $6.2M | $10.6M |
| Net Profit | $-122.8M | $76.5M |
| Gross Margin | — | -126.4% |
| Operating Margin | -2169.6% | -152.8% |
| Net Margin | -1993.4% | 721.7% |
| Revenue YoY | — | 10.4% |
| Net Profit YoY | -52.4% | 504.8% |
| EPS (diluted) | $-1.30 | $13.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.2M | $10.6M | ||
| Q3 25 | — | $11.7M | ||
| Q2 25 | $1.0M | $7.6M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | $0 | $9.6M | ||
| Q3 24 | $0 | $10.4M | ||
| Q2 24 | — | $8.9M | ||
| Q1 24 | — | $10.4M |
| Q4 25 | $-122.8M | $76.5M | ||
| Q3 25 | — | $-26.4M | ||
| Q2 25 | $-115.6M | $-26.1M | ||
| Q1 25 | — | $-13.4M | ||
| Q4 24 | $-80.6M | $-18.9M | ||
| Q3 24 | $-76.8M | $-15.6M | ||
| Q2 24 | — | $-22.0M | ||
| Q1 24 | — | $-24.8M |
| Q4 25 | — | -126.4% | ||
| Q3 25 | — | -92.3% | ||
| Q2 25 | — | -168.4% | ||
| Q1 25 | — | -71.2% | ||
| Q4 24 | — | -122.9% | ||
| Q3 24 | — | -98.1% | ||
| Q2 24 | — | -131.5% | ||
| Q1 24 | — | -93.3% |
| Q4 25 | -2169.6% | -152.8% | ||
| Q3 25 | — | -171.8% | ||
| Q2 25 | -12523.0% | -259.2% | ||
| Q1 25 | — | -65.3% | ||
| Q4 24 | — | -142.7% | ||
| Q3 24 | — | -92.3% | ||
| Q2 24 | — | -185.4% | ||
| Q1 24 | — | -185.6% |
| Q4 25 | -1993.4% | 721.7% | ||
| Q3 25 | — | -225.6% | ||
| Q2 25 | -11216.0% | -343.4% | ||
| Q1 25 | — | -113.6% | ||
| Q4 24 | — | -196.9% | ||
| Q3 24 | — | -150.0% | ||
| Q2 24 | — | -247.2% | ||
| Q1 24 | — | -238.5% |
| Q4 25 | $-1.30 | $13.65 | ||
| Q3 25 | — | $-6.55 | ||
| Q2 25 | $-1.23 | $-6.58 | ||
| Q1 25 | — | $-2.72 | ||
| Q4 24 | $-0.86 | $-4.70 | ||
| Q3 24 | $-0.96 | $-4.17 | ||
| Q2 24 | — | $-6.03 | ||
| Q1 24 | — | $-5.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $50.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $992.1M | $-35.1M |
| Total Assets | $1.1B | $231.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.0B | $50.7M | ||
| Q3 25 | — | $43.6M | ||
| Q2 25 | $1.2B | $70.4M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | $1.4B | $74.1M | ||
| Q3 24 | $862.7M | $76.6M | ||
| Q2 24 | — | $82.0M | ||
| Q1 24 | — | $84.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $340.6M | ||
| Q1 25 | — | $333.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $992.1M | $-35.1M | ||
| Q3 25 | — | $-232.1M | ||
| Q2 25 | $1.2B | $-207.1M | ||
| Q1 25 | — | $-182.5M | ||
| Q4 24 | $1.3B | $-171.2M | ||
| Q3 24 | $833.0M | $-154.5M | ||
| Q2 24 | — | $-141.3M | ||
| Q1 24 | — | $-122.3M |
| Q4 25 | $1.1B | $231.0M | ||
| Q3 25 | — | $219.0M | ||
| Q2 25 | $1.3B | $245.3M | ||
| Q1 25 | — | $240.0M | ||
| Q4 24 | $1.4B | $251.6M | ||
| Q3 24 | $937.4M | $257.4M | ||
| Q2 24 | — | $278.4M | ||
| Q1 24 | — | $278.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-92.9M | $-1.4M |
| Free Cash FlowOCF − Capex | $-93.4M | — |
| FCF MarginFCF / Revenue | -1515.3% | — |
| Capex IntensityCapex / Revenue | 7.4% | — |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | $-311.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-92.9M | $-1.4M | ||
| Q3 25 | — | $-10.5M | ||
| Q2 25 | $-85.9M | $8.3M | ||
| Q1 25 | — | $1.4M | ||
| Q4 24 | $-64.7M | $4.7M | ||
| Q3 24 | $-62.8M | $2.2M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | $-8.0M |
| Q4 25 | $-93.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-89.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-65.7M | — | ||
| Q3 24 | $-63.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -1515.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -8637.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 7.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 310.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRNX
| Products | $5.4M | 88% |
| Other | $741.0K | 12% |
RENT
Segment breakdown not available.
